Union européenne - letton - EMA (European Medicines Agency)

dechra regulatory b.v. - mirtazapīns - psychoanaleptics, antidepressants in combination with psycholeptics - kaķi - par svara pieaugumu kaķi piedzīvo sliktas apetītes un svara zudums, kas izriet no hroniskas slimības.

Union européenne - letton - EMA (European Medicines Agency)

stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastiski līdzekļi - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).

Union européenne - letton - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Union européenne - letton - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastiski līdzekļi - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Union européenne - letton - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - sleep apnea, obstructive - other nervous system drugs - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

Union européenne - letton - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - plaušu slimība, hroniska obstruktīva - zāles obstruktīvu elpceļu slimību, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Lettonie - letton - Zāļu valsts aģentūra

egis pharmaceuticals plc, hungary - atorvastatinum, perindoprili argininum - kapsula, cietā - 10 mg/5 mg

Lettonie - letton - Zāļu valsts aģentūra

egis pharmaceuticals plc, hungary - atorvastatinum, perindoprili argininum - kapsula, cietā - 20 mg/5 mg

Lettonie - letton - Zāļu valsts aģentūra

egis pharmaceuticals plc, hungary - atorvastatinum, perindoprili argininum - kapsula, cietā - 40 mg/5 mg

Lettonie - letton - Zāļu valsts aģentūra

egis pharmaceuticals plc, hungary - atorvastatinum, perindoprili argininum - kapsula, cietā - 10 mg/10 mg